Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16113,144,2.81 [1.06-7.44],0.0371522463549216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18197,158,1.50 [1.17-1.93],0.0012741648502444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18344,165,2.09 [1.26-3.46],0.0043178697563238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,18443,162,2.21 [1.66-2.94],5.4140931662917124e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15604,137,1.97 [1.34-2.90],0.0005794627888039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18665,169,3.38 [2.46-4.64],5.509907066044508e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16036,144,2.47 [1.57-3.87],8.356586216738678e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18574,169,0.67 [0.50-0.89],0.0065002205533521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,15738,143,0.65 [0.43-0.98],0.0389141745620148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,16036,144,1.98 [1.53-2.57],1.9128262505678e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18589,167,2.66 [1.72-4.13],1.201131425317707e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18668,167,2.34 [1.73-3.15],2.4270537644325685e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFM,Afamin,16113,144,0.41 [0.19-0.89],0.0242330169891734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18309,163,1.26 [1.02-1.56],0.0299320275110844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,18001,163,1.17 [1.02-1.35],0.0263512797179235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18589,167,1.49 [1.02-2.19],0.0392314930379367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15641,140,1.64 [1.03-2.60],0.0371496940574297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18759,168,2.20 [1.11-4.37],0.0240819556240682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15086,137,1.37 [1.05-1.78],0.0193710147132049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,18567,166,1.47 [1.08-2.00],0.0144463466334226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18440,167,1.45 [1.14-1.85],0.0025152437453722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,15641,140,0.68 [0.48-0.98],0.0386684634301043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15529,136,0.69 [0.53-0.91],0.0074070257170059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16110,145,1.92 [1.08-3.40],0.0262215712359375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,16036,144,1.63 [1.15-2.33],0.0065774737653071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16113,144,1.67 [1.37-2.03],2.799596182115364e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18589,167,2.64 [1.65-4.22],4.868354635050197e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,18107,161,2.22 [1.49-3.32],9.296905171616162e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,16058,142,1.26 [1.05-1.51],0.0124546679926995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,16036,144,1.83 [1.57-2.12],3.546781195099788e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,18081,161,1.13 [1.00-1.27],0.0430103791889367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,18524,168,0.81 [0.65-1.00],0.0490867668882934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15604,137,1.87 [1.41-2.46],1.04579065678729e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18133,164,1.46 [1.09-1.96],0.0109570664102727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18697,171,1.58 [1.08-2.30],0.01847661922371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18697,171,1.31 [1.02-1.68],0.0321487622764278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18589,167,2.61 [1.65-4.12],4.046006756173462e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18524,168,1.81 [1.33-2.48],0.0001952992432471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18660,169,4.09 [2.51-6.66],1.5243963941705382e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,16078,144,3.39 [1.47-7.82],0.0041494252355327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,15730,140,1.85 [1.12-3.08],0.0171348216270296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,16110,145,1.50 [1.12-1.99],0.0058291211681605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18107,161,1.37 [1.02-1.82],0.0335027770330915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18465,166,3.73 [1.90-7.31],0.0001263083447862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,18701,165,0.56 [0.36-0.86],0.0078826617859019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18501,163,1.53 [1.15-2.05],0.003949861641426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,18589,167,1.49 [1.11-1.99],0.0071880939949287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18310,165,1.31 [1.01-1.68],0.0379921767273782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,18567,166,1.31 [1.11-1.54],0.0011145905409482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18524,168,1.36 [1.19-1.56],5.423348616968655e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18530,166,1.29 [1.10-1.51],0.0015229918466866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18617,166,0.85 [0.75-0.98],0.0212301195780151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18188,161,1.49 [1.07-2.08],0.0186217058921323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18751,169,1.60 [1.22-2.09],0.0006516153335662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18617,166,1.47 [1.08-2.00],0.0141453096910037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18574,169,3.05 [1.74-5.35],9.735342451255384e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18524,168,2.10 [1.35-3.26],0.0009426737947456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18751,169,2.77 [2.21-3.47],5.247327527994316e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18574,169,3.58 [2.78-4.61],6.911185573363639e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18379,166,2.13 [1.52-2.98],1.1179967666059463e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18107,161,2.35 [1.97-2.79],5.1679272765579e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15738,143,2.39 [1.46-3.89],0.0004960505533436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18697,171,1.96 [1.35-2.83],0.000350571652006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18647,165,2.29 [1.70-3.07],3.8627386335669664e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18701,165,1.61 [1.24-2.09],0.0003341320640242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,18492,168,1.65 [1.17-2.32],0.0042217877220029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18567,166,4.43 [2.93-6.68],1.4015014763896045e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18675,165,3.27 [2.61-4.09],6.9876703666725635e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,16042,141,1.82 [1.31-2.53],0.0003359222209807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18718,169,1.63 [1.25-2.11],0.0002671049954588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15577,137,1.91 [1.43-2.55],1.265366331940265e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18524,168,3.26 [2.57-4.14],2.9809355632832303e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15738,143,4.82 [3.73-6.23],2.2242019343165577e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18697,171,3.44 [2.45-4.81],6.967717005977836e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18751,169,3.62 [2.99-4.38],1.2305303113007916e-39
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16089,144,5.38 [4.03-7.19],4.440470395150911e-30
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18524,168,3.58 [2.55-5.01],1.4772221450671678e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,16036,144,2.98 [1.84-4.81],8.853307467910261e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18697,171,1.40 [1.10-1.80],0.006972034606732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18379,166,1.35 [1.07-1.70],0.011575831946092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18697,171,2.37 [1.69-3.32],5.761062540514749e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18528,166,0.53 [0.32-0.87],0.0113918229244338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16036,144,1.78 [1.26-2.52],0.0010164065122535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18524,168,1.24 [1.06-1.44],0.0056486060591008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18197,158,1.35 [1.03-1.76],0.0309354876803052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,18574,168,0.78 [0.66-0.92],0.004154850950384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,18440,167,0.67 [0.53-0.85],0.0007288515075632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,18107,161,1.31 [1.01-1.71],0.0449574179346743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,15999,144,1.83 [1.31-2.56],0.0004121727082862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,16079,144,1.43 [1.12-1.82],0.0035474991310628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,15908,141,1.72 [1.14-2.60],0.0099378674644697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18530,168,1.39 [1.14-1.70],0.0010921038680817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15738,143,0.68 [0.48-0.95],0.0254170363443369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16058,142,1.58 [1.15-2.18],0.0046953796795813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,16032,144,1.73 [1.10-2.71],0.01710272939697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,16098,144,1.24 [1.06-1.45],0.0061437230887884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15673,134,1.49 [1.13-1.98],0.0048727825787372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18659,168,2.15 [1.52-3.04],1.3085120302697074e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,16098,144,1.56 [1.19-2.06],0.001326790467972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18444,165,0.80 [0.66-0.97],0.0263345473435182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15604,137,2.86 [1.78-4.57],1.2106305356118062e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,18467,165,2.00 [1.31-3.06],0.0013599625386885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,18107,161,1.93 [1.49-2.49],5.580205297840252e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,18751,169,1.55 [1.16-2.08],0.0032514265304659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,16058,142,2.13 [1.36-3.33],0.0009614225164238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18617,166,0.73 [0.55-0.97],0.0274824034267506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,18530,168,0.52 [0.32-0.83],0.0063366307663425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,18530,168,0.55 [0.31-0.98],0.04274815285634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18602,166,1.81 [1.01-3.24],0.0450849668237388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18528,166,1.75 [1.26-2.43],0.0008838794479481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18759,168,1.59 [1.10-2.28],0.0127606215187371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18498,166,1.79 [1.09-2.95],0.0215998964284283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,18666,165,1.52 [1.07-2.16],0.0185280751105222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,16053,144,2.21 [1.44-3.39],0.0002990804038661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18617,166,2.10 [1.59-2.78],2.275448848533689e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18589,167,2.26 [1.17-4.36],0.0147227988897476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18379,166,3.45 [2.70-4.39],1.3148122998172857e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18589,167,2.77 [1.72-4.45],2.7885228048789594e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16110,145,1.62 [1.14-2.30],0.0071077492583631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,15563,139,0.60 [0.37-0.98],0.0422341056747094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18379,166,1.27 [1.04-1.56],0.0209807806513566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,15604,137,1.56 [1.05-2.32],0.0269212469108736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18216,160,1.37 [1.04-1.79],0.0232694993069056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15563,139,1.17 [1.02-1.35],0.0268583483447251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18582,166,1.66 [1.05-2.63],0.030655751205782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,18534,166,1.36 [1.06-1.75],0.0150854009201687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18528,166,2.50 [1.48-4.22],0.0006298288119894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,18751,169,1.57 [1.03-2.39],0.035163621595366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18632,165,0.58 [0.40-0.84],0.0036909632947807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18557,164,1.68 [1.10-2.58],0.0169143639935589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15945,144,1.28 [1.05-1.56],0.0143104886488381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18589,167,1.30 [1.08-1.57],0.0053342529047071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18697,171,1.27 [1.09-1.46],0.0014246776176906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18697,171,1.70 [1.56-1.85],3.856602613081957e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18466,166,0.87 [0.77-0.98],0.0243553573874034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18589,167,1.76 [1.52-2.05],1.0300368279006877e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18528,166,3.56 [2.45-5.18],3.125139872982128e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18697,171,1.84 [1.05-3.24],0.0328477531081071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,18183,163,1.33 [1.07-1.67],0.0112541485616331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,18245,167,1.10 [1.00-1.21],0.0496990470074321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,15563,139,0.62 [0.39-0.99],0.0431075176720599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,15604,137,0.72 [0.53-0.99],0.046323012344939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,16032,144,1.63 [1.26-2.13],0.0002622705812936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18574,169,2.38 [1.56-3.62],5.306763508001373e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,18203,159,0.53 [0.32-0.89],0.0156154158541675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18650,165,1.24 [1.00-1.53],0.0472639032573703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18300,167,2.36 [1.65-3.38],2.41695115589168e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,15994,144,1.45 [1.05-2.00],0.0235052894709554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18440,167,2.24 [1.36-3.69],0.0014541875509992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,16032,144,0.63 [0.42-0.94],0.0242939432834136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18678,165,3.61 [2.37-5.49],1.8944906740563366e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18701,165,1.84 [1.32-2.57],0.0003598507780428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18524,168,0.83 [0.71-0.96],0.0145742785044005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,15641,140,1.75 [1.02-3.00],0.0434205569643764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,16036,144,1.66 [1.16-2.38],0.0057918648925924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18498,167,1.83 [1.18-2.85],0.0067393075879264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18344,165,3.52 [2.52-4.92],1.954725103172421e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,18107,161,1.45 [1.04-2.02],0.0266201323502134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18524,168,1.26 [1.04-1.52],0.0198677580204683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,15641,140,0.86 [0.75-0.98],0.0264392833696753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,15641,140,0.72 [0.54-0.97],0.0313733177056152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18759,168,2.81 [1.66-4.74],0.0001170574460999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17885,164,1.95 [1.30-2.93],0.0011440420366215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15738,143,1.82 [1.05-3.16],0.0331715977237712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18351,166,2.47 [1.65-3.69],1.12748225167278e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18524,168,1.38 [1.19-1.60],1.8955500497840205e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,18574,169,0.47 [0.29-0.76],0.002000356235398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,18414,167,0.55 [0.32-0.94],0.0294703793912636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18697,171,2.88 [1.81-4.57],7.692649272843407e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,16098,144,1.78 [1.07-2.95],0.0250788879571298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16089,144,2.05 [1.67-2.51],3.2138772635144187e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18530,168,2.19 [1.81-2.65],7.375527247985645e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18528,166,2.76 [2.21-3.45],2.9930882428140603e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18665,167,2.92 [2.51-3.41],2.461537050218645e-43
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18216,160,2.38 [1.92-2.93],8.895814049464475e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18530,168,1.67 [1.32-2.10],1.3571447999262996e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,18524,168,1.37 [1.12-1.68],0.0021577749243975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18107,161,1.43 [1.22-1.68],9.80841646274474e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,18574,169,0.61 [0.41-0.90],0.0130053176203234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18379,166,1.68 [1.06-2.68],0.0285072635208341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,16058,142,0.64 [0.46-0.90],0.0099990945928498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18697,171,1.63 [1.03-2.57],0.0372803537737681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15641,140,1.49 [1.14-1.96],0.0038736416626254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18468,166,1.85 [1.23-2.76],0.002871565514704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FURIN,Furin,18574,169,0.51 [0.34-0.77],0.0013184343567408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18440,167,1.68 [1.03-2.74],0.0360092057374377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18216,160,1.76 [1.32-2.34],0.0001230437174026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,16030,142,1.63 [1.32-2.02],7.795605295823723e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18216,160,1.25 [1.01-1.55],0.0363854170272175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15358,137,1.40 [1.06-1.84],0.0168648108092477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18440,167,2.91 [2.03-4.18],6.031264746480841e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18759,168,1.56 [1.20-2.04],0.0009314217743958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18528,166,0.62 [0.42-0.91],0.0154857666989599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18678,165,1.68 [1.05-2.69],0.0313451571887848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,15738,143,0.48 [0.27-0.85],0.012214675684701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,15738,143,1.72 [1.19-2.48],0.0038476712025894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,16058,142,2.22 [1.45-3.41],0.0002394410114777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,15604,137,0.62 [0.40-0.97],0.035579168845397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18697,171,1.82 [1.17-2.83],0.0079756230273555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,18701,165,0.51 [0.32-0.82],0.0054803373338128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",16064,141,0.60 [0.38-0.94],0.0270954896582337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18430,167,2.81 [1.69-4.67],7.226183805546085e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",18440,167,1.28 [1.04-1.58],0.022561191690785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18751,169,2.50 [1.81-3.44],2.2932415220369213e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18197,158,1.24 [1.07-1.42],0.0031571139053906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18530,168,1.94 [1.36-2.77],0.00023731284584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,15967,142,0.51 [0.30-0.88],0.0150118712215531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,16021,140,1.41 [1.11-1.77],0.004342432002199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18524,168,2.22 [1.49-3.30],8.289745891837417e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,18329,164,1.36 [1.04-1.78],0.0262528904436905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18133,164,1.39 [1.09-1.76],0.006841203317682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18294,165,1.45 [1.09-1.93],0.0103023786452574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,18107,161,0.67 [0.45-0.98],0.038701283897051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18701,165,1.57 [1.19-2.08],0.0014407188498684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,18238,165,0.83 [0.69-1.00],0.0459797589534742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18701,165,1.49 [1.08-2.04],0.015350887193743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18469,163,2.41 [1.54-3.76],0.0001114137587587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18759,168,1.59 [1.04-2.43],0.0312696704765957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18759,168,6.01 [4.04-8.95],1.1035349965158132e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",15641,140,1.36 [1.08-1.72],0.0098842717235417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15666,136,2.64 [1.87-3.71],2.653291530615654e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,16036,144,1.79 [1.05-3.02],0.0308254554575213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18216,160,1.15 [1.01-1.30],0.0297979193996854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18589,167,2.26 [1.36-3.76],0.0016426096082807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,18133,164,1.62 [1.25-2.10],0.0002972591035946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18524,168,1.90 [1.49-2.44],3.525149590311647e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,18729,168,1.50 [1.20-1.89],0.0004665904219099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18306,167,1.44 [1.08-1.91],0.0124924996344197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18440,167,1.70 [1.18-2.43],0.0039434072820656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,16089,144,0.81 [0.67-0.98],0.0304660169490384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18216,160,1.44 [1.27-1.62],8.345229741168562e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,18216,160,1.22 [1.00-1.48],0.0453008627150979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18589,167,1.76 [1.20-2.58],0.0036297668337207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18440,167,1.97 [1.69-2.30],2.7452244562872052e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18751,169,2.68 [2.12-3.38],1.3631132992441798e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18216,160,2.30 [1.67-3.16],3.170225859945955e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18216,160,2.29 [1.55-3.38],3.096336957448554e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18751,169,1.51 [1.16-1.97],0.0019854491576442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18434,165,1.75 [1.32-2.32],0.0001006480991943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18617,166,2.74 [1.86-4.03],3.59654211837712e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,18751,169,1.68 [1.12-2.51],0.0120520291658452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18498,167,2.04 [1.18-3.51],0.0106955051857195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18411,165,3.34 [2.68-4.17],1.440439077737359e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,18216,160,1.39 [1.01-1.90],0.0417622488192656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,16032,144,1.52 [1.10-2.10],0.0121039593541965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,18524,168,1.61 [1.23-2.10],0.000463505989735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18524,168,1.66 [1.16-2.36],0.0053028506009902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18440,167,1.30 [1.13-1.50],0.0002416814134405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,16058,142,0.83 [0.70-0.99],0.0375209852031603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17858,163,0.62 [0.43-0.89],0.0092683151488152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18524,168,0.55 [0.37-0.83],0.003861207602399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18524,168,0.73 [0.55-0.97],0.0308389903111242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15604,137,1.85 [1.24-2.76],0.002621473528538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,18701,165,0.44 [0.20-0.99],0.0476643969424945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18436,163,2.05 [1.34-3.14],0.0009020317779857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,18701,165,1.43 [1.08-1.89],0.0113410513712002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,16098,144,1.78 [1.23-2.57],0.0021163285519394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18617,166,1.61 [1.12-2.31],0.0094353428337561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,18524,168,1.28 [1.03-1.59],0.0251214293328798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,18216,160,1.29 [1.03-1.62],0.0243706666841212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18216,160,1.31 [1.06-1.63],0.0131652506456027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18440,167,1.40 [1.01-1.92],0.0406509335787565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15737,135,1.73 [1.38-2.16],1.6098011692194253e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18574,169,0.59 [0.36-0.97],0.0379982651907499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18107,161,0.85 [0.76-0.96],0.0066864876785149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,18594,165,0.54 [0.34-0.87],0.0104364164170806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18701,165,1.34 [1.11-1.62],0.0028851205678097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18751,169,2.07 [1.49-2.89],1.723604660421665e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18751,169,1.76 [1.33-2.34],9.344151116809842e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,16058,142,1.83 [1.44-2.32],8.522573829523155e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18440,167,1.96 [1.53-2.51],8.237458562925582e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18498,166,2.09 [1.60-2.74],7.782302589366663e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18379,166,1.32 [1.15-1.52],0.0001101514685107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18351,166,1.71 [1.19-2.46],0.0036365980986036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,18498,165,1.35 [1.01-1.82],0.0460180451818172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18508,165,3.44 [2.33-5.07],4.2527933647340424e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18530,168,1.81 [1.21-2.71],0.0038247841399546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18507,165,1.94 [1.28-2.94],0.0016772860463258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18759,168,2.51 [1.54-4.11],0.0002293826770917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18668,167,1.57 [1.04-2.37],0.0315396444820941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18216,160,2.13 [1.59-2.86],4.19589484968707e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,16009,144,1.25 [1.01-1.55],0.0398816735773054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,16058,142,2.95 [2.02-4.32],2.266976641688685e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16113,144,2.85 [1.61-5.04],0.0003203905045744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18652,165,2.19 [1.52-3.16],2.322211467193132e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18440,167,1.38 [1.02-1.87],0.0389866079720912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18216,160,0.67 [0.48-0.95],0.025272803368235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15673,134,1.43 [1.08-1.88],0.0120639312871514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18524,168,1.62 [1.18-2.23],0.0027529429723658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,18524,168,2.40 [1.93-2.98],3.5243964161123235e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18759,168,2.07 [1.36-3.13],0.0006388111989478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18405,165,2.08 [1.36-3.19],0.0007485848396128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18412,166,1.67 [1.22-2.29],0.0013745325161887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18524,168,1.74 [1.20-2.51],0.0033995382550842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18300,166,6.36 [4.39-9.22],1.6786108620822801e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18107,161,1.22 [1.01-1.48],0.0443059210350286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,18107,161,1.27 [1.02-1.59],0.0306472322162491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,15529,136,0.49 [0.29-0.81],0.0061880536760476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18321,165,1.43 [1.19-1.72],0.0001548465428295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,15807,138,0.82 [0.70-0.96],0.0128920524300126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15641,140,3.10 [1.63-5.88],0.0005537874529646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,15563,139,1.27 [1.02-1.58],0.0359082893217065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15598,136,0.55 [0.33-0.93],0.0243179662917327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18528,166,2.84 [1.66-4.88],0.0001522069635692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18751,169,1.79 [1.04-3.09],0.036198372363522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,18574,169,1.46 [1.03-2.06],0.033333840084588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18216,160,1.46 [1.13-1.90],0.004325376429487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18571,165,1.29 [1.01-1.65],0.0380841118960502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,16089,144,1.29 [1.02-1.64],0.0354009443954348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,18530,168,1.56 [1.22-1.99],0.0003549118298064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,16098,144,0.82 [0.69-0.98],0.0312658124896749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15529,136,0.57 [0.35-0.93],0.0243664063119215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,15641,140,1.28 [1.04-1.57],0.0174297463650696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18550,167,1.32 [1.02-1.71],0.0357181521938234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18297,164,1.28 [1.03-1.59],0.0254971239795292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15612,139,1.38 [1.05-1.82],0.0228850967771287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16036,144,1.97 [1.29-3.00],0.0017572996408867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18507,165,1.65 [1.08-2.53],0.02104326542215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,18080,163,1.39 [1.07-1.83],0.0155662356403864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,15807,138,0.67 [0.51-0.89],0.006269052983071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18574,169,0.71 [0.51-0.98],0.0396944182350147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,18751,169,1.70 [1.07-2.69],0.0245873501428011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18107,161,1.50 [1.15-1.95],0.0026685370422002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15563,139,1.38 [1.02-1.88],0.0376500153313573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,16089,144,1.52 [1.00-2.30],0.0494824849376309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15369,139,2.56 [1.50-4.38],0.0005804617241213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18379,166,1.18 [1.01-1.38],0.0335837412359299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",18133,164,1.42 [1.14-1.75],0.001499868492758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18133,164,1.93 [1.70-2.19],5.9415557588416204e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18759,168,4.62 [2.01-10.60],0.000302644664634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15831,138,2.24 [1.47-3.43],0.0001978574270534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18528,166,1.66 [1.13-2.43],0.0091851200662674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,18197,158,1.11 [1.00-1.23],0.0400851647346837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,18524,168,1.28 [1.00-1.65],0.0480345443549666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18528,166,1.81 [1.14-2.90],0.0126914259192781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18530,168,1.82 [1.17-2.83],0.008187587878203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,18216,160,1.29 [1.02-1.64],0.0348578278229067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,18107,161,1.36 [1.02-1.81],0.0333065020211912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18528,166,1.21 [1.08-1.35],0.0008246105939047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,15807,138,1.30 [1.08-1.57],0.0063032619515934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18440,167,1.77 [1.18-2.65],0.0059527506149088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,16052,144,4.02 [1.99-8.09],9.857137374321972e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,16058,142,1.51 [1.19-1.92],0.0008366238175131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18528,166,1.82 [1.22-2.72],0.0034070439666445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,16064,141,0.76 [0.58-0.99],0.0428784610316647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,18379,166,1.14 [1.01-1.29],0.0324699550767077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18524,168,1.29 [1.08-1.53],0.004625299932788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,18528,166,1.50 [1.05-2.16],0.0269771908969541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18668,164,5.28 [4.38-6.37],2.507286980722216e-68
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18440,167,1.61 [1.06-2.43],0.0252491862699451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18751,169,2.17 [1.39-3.39],0.0007024209308309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,18668,167,1.38 [1.03-1.86],0.0323102548901548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,15673,134,1.27 [1.04-1.54],0.0182208851046038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18530,168,1.78 [1.15-2.76],0.0095601810857475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18530,168,1.51 [1.08-2.09],0.014656248836319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18528,166,1.37 [1.06-1.78],0.0146459339873259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,18698,167,0.63 [0.49-0.81],0.0003928607544755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18383,164,2.67 [1.69-4.20],2.4094071356835923e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",16058,142,0.73 [0.56-0.94],0.0168682980418386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18675,167,2.12 [1.26-3.59],0.0049777971950673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,18440,167,0.37 [0.15-0.90],0.0286849923497871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15604,137,1.38 [1.02-1.86],0.036681483462737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18440,167,1.55 [1.17-2.05],0.0020990845827304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18107,161,1.28 [1.07-1.54],0.007116579619793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,18640,166,1.77 [1.17-2.67],0.0064689996763526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15641,140,1.65 [1.09-2.50],0.019022428988821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,18069,161,1.45 [1.16-1.81],0.0009686336366905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,15956,140,2.00 [1.20-3.34],0.0080822167167405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18417,162,1.72 [1.16-2.55],0.0075353439700569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,16089,144,0.81 [0.67-0.98],0.0330898169395793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16098,144,5.44 [3.31-8.94],2.1629834709253904e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,16036,144,1.63 [1.21-2.19],0.0013116855845238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16113,144,2.06 [1.39-3.05],0.000294851916044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,18541,165,2.55 [1.54-4.23],0.0002840329140305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15790,140,1.39 [1.07-1.79],0.0124286883767334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18107,161,1.24 [1.02-1.51],0.029087424798414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,16064,141,1.56 [1.12-2.16],0.0079647259809348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,16064,141,0.80 [0.64-0.99],0.0442628035263437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18440,167,1.31 [1.04-1.67],0.0246805156498491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,18197,158,1.30 [1.00-1.67],0.0475432836048751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18438,162,1.34 [1.03-1.73],0.0278578459002957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18530,168,2.28 [1.51-3.43],7.78993179458739e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15563,139,0.49 [0.30-0.80],0.0044590080521307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,16002,144,1.85 [1.42-2.40],4.528871694024744e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18672,166,2.90 [1.87-4.51],2.1680233193862824e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15641,140,2.78 [1.76-4.41],1.237793791050864e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,18107,161,1.24 [1.01-1.52],0.0363618825394281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18528,166,3.34 [1.99-5.60],5.168508515726097e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18528,166,1.68 [1.10-2.58],0.0172285549162029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15641,140,1.67 [1.23-2.27],0.0010514317115825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18107,161,1.77 [1.50-2.08],1.035888952033823e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,16032,144,1.34 [1.07-1.69],0.0106448048894255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15563,139,1.60 [1.26-2.03],9.895032944131474e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,18023,160,2.26 [1.56-3.28],1.708986300731164e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15738,143,1.95 [1.06-3.57],0.0315510578571026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,18528,166,1.62 [1.18-2.23],0.0030417412181845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18528,166,0.66 [0.49-0.87],0.0038650692114696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15738,143,2.20 [1.65-2.92],6.05272048011459e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,15641,140,1.43 [1.01-2.03],0.0449855337978157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16113,144,4.33 [2.41-7.78],9.134881036193898e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18528,166,1.78 [1.06-2.97],0.0285354132169616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15738,143,1.70 [1.25-2.31],0.0007149500696037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18440,167,1.51 [1.06-2.15],0.0239346913808469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18697,171,1.98 [1.26-3.12],0.0031743678597158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18698,167,5.77 [4.05-8.21],2.3201331303523235e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,16026,142,1.55 [1.00-2.39],0.0497471866036903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,15817,141,3.81 [1.00-14.46],0.0495329775287255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,16069,143,2.78 [1.45-5.35],0.0021430078209693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,16113,144,2.70 [1.19-6.11],0.0175558977091001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18362,167,1.62 [1.36-1.92],5.722770786970362e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18751,169,1.28 [1.07-1.53],0.0075678285588024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18309,163,1.69 [1.11-2.58],0.013799354695744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,18524,168,1.38 [1.15-1.64],0.0003819421555102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15598,136,0.58 [0.40-0.86],0.0058219302101032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,15712,138,0.82 [0.69-0.97],0.0239998290441956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16098,144,2.36 [1.49-3.72],0.0002321523174597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18589,167,1.50 [1.09-2.08],0.0132596456804261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18524,168,5.31 [3.94-7.16],8.131331010842896e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18701,165,3.19 [2.24-4.54],1.3030113193678434e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15641,140,2.09 [1.48-2.94],2.5553068377976933e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18576,166,1.35 [1.04-1.75],0.0241874870331137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18464,166,1.89 [1.43-2.51],7.346578308952675e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18133,164,0.71 [0.52-0.97],0.029700573615335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,16064,141,0.85 [0.73-0.98],0.0300360703220162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,18216,160,1.41 [1.11-1.79],0.0055027710725131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18107,161,2.74 [2.10-3.58],1.0433929248745544e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18107,161,2.56 [1.99-3.30],2.800152228359273e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18701,165,1.61 [1.15-2.25],0.0051203130159011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18440,167,0.45 [0.24-0.83],0.0109408485602621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,16036,144,1.34 [1.11-1.61],0.0019963136473131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,18701,165,1.50 [1.00-2.25],0.0488858620260625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,15598,136,0.73 [0.54-1.00],0.0498565540303156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',16058,142,1.36 [1.11-1.68],0.003485315373204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,18107,161,1.81 [1.23-2.67],0.0027507380698739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,16026,141,1.74 [1.02-2.97],0.0416256680853097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18530,168,1.51 [1.10-2.06],0.0105212747273014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,18530,168,0.65 [0.43-0.97],0.0336279473085763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18462,166,2.16 [1.33-3.53],0.0020171222052857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,16036,144,0.89 [0.81-0.98],0.0136565457794067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,18379,166,0.48 [0.29-0.82],0.0074850413413705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15598,136,0.52 [0.29-0.95],0.0332345855835802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18507,165,0.87 [0.78-0.98],0.02188528886763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18697,171,1.68 [1.29-2.21],0.0001604584944404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,18197,158,0.71 [0.54-0.94],0.0178765065204648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,16032,144,1.57 [1.15-2.14],0.0045709594927529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,15666,142,1.62 [1.00-2.60],0.0477342864354995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,16036,144,1.86 [1.42-2.45],8.488519950578523e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,15794,144,1.44 [1.01-2.05],0.0411913630553264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16089,144,2.40 [1.84-3.14],1.4106412071074954e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,16032,144,1.22 [1.02-1.46],0.028113269389222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,15778,138,0.77 [0.62-0.97],0.0250144878791912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18533,164,1.49 [1.09-2.03],0.0121336580681224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18520,169,1.33 [1.02-1.72],0.0332806526457207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18495,165,0.83 [0.69-1.00],0.0448546215977078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18528,166,1.66 [1.09-2.54],0.0189039912239082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18444,165,1.55 [1.03-2.34],0.0353510761172599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18697,171,1.65 [1.04-2.62],0.0331539063407077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15807,138,1.77 [1.50-2.10],3.8776553732968335e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18617,166,1.53 [1.12-2.09],0.0079483247189549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18478,165,2.46 [1.33-4.54],0.0040611702979197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15807,138,1.43 [1.09-1.89],0.0109075987544812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15604,137,2.25 [1.33-3.82],0.0025010779734607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18617,166,1.87 [1.43-2.45],5.042764077027037e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18172,158,1.87 [1.54-2.28],3.1431386107152977e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18379,166,2.14 [1.58-2.89],8.816642039974922e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18379,166,1.40 [1.20-1.64],1.5306929250413463e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18751,169,1.56 [1.12-2.17],0.0081797480830389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18528,166,3.69 [3.13-4.34],8.722936165646858e-56
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18216,160,3.41 [2.84-4.08],3.3793116888313806e-40
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18528,166,1.83 [1.21-2.77],0.0040760361694628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15738,143,2.48 [1.72-3.58],1.146415312244282e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18701,165,1.74 [1.19-2.56],0.0046511767379532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18530,168,1.96 [1.31-2.93],0.0010376170372653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18530,168,1.72 [1.42-2.10],5.3546756640579054e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18718,169,4.54 [3.53-5.86],1.4297661544536362e-31
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18379,166,1.66 [1.37-2.01],2.732677978004109e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18697,171,3.06 [2.50-3.75],1.4812738800377662e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18524,168,1.27 [1.01-1.59],0.0370143433853288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16098,144,2.99 [2.20-4.06],2.873977634955671e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",15529,136,0.62 [0.41-0.94],0.0251540066569852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15604,137,1.23 [1.03-1.47],0.0238938059450562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16089,144,1.76 [1.01-3.09],0.0479858572021129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15563,139,1.39 [1.12-1.72],0.0026119863123851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15604,137,1.45 [1.04-2.02],0.0285357875876736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,16098,144,0.81 [0.66-1.00],0.0496335240317395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18530,168,2.06 [1.40-3.02],0.0002299738039371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18379,166,1.84 [1.33-2.55],0.000238677365682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,18197,158,1.26 [1.01-1.57],0.0440584758169615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18594,165,5.64 [3.73-8.53],2.8126721861430665e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,16110,145,0.76 [0.62-0.93],0.0080681925048127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,16032,144,1.35 [1.08-1.69],0.0072972954327369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18508,168,1.70 [1.24-2.33],0.0008859539092247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18197,158,0.75 [0.57-0.98],0.0374654092459854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18530,168,1.67 [1.17-2.39],0.0046133389487871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,16032,144,1.49 [1.06-2.10],0.0224405844260564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17594,160,1.65 [1.20-2.25],0.0017929664482441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18701,165,1.42 [1.15-1.74],0.0010080856535948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,16058,142,1.79 [1.07-2.98],0.0257916241100589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15604,137,1.77 [1.35-2.32],4.175554019931506e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18197,158,1.66 [1.34-2.05],3.245351276517112e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15563,139,1.25 [1.01-1.56],0.0401687715944672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,16058,142,1.74 [1.35-2.23],1.4912948207756862e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15529,136,0.43 [0.21-0.87],0.0185447564870094
